exendin 4 tirzepatide Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond Exendin-4(1-32)K-Capric Acid, a Glucagon-Like Peptide-1

This question arises frequently as tirzepatide (Mounjaro, Zepbound) gains recognition for substantial weight loss in clinical trials

Study data can be requested after publication through the corresponding author

Anticoagulants (warfarin, apixaban, rivaroxaban), antiplatelet drugs (aspirin, clopidogrel), and certain anti-inflammatories (NSAIDs) increase bleeding risk and can lead to easier bruising

a package shipped in July in Arizona needs different insulation than one shipped in January in Maine

These data highlight the importance of closely monitoring the safety profile of GLP-1RA plus SGLT2i combination therapy in routine clinical practice

A 2025 preclinical bioRxiv preprint reported that low-dose semaglutide produced cardiac and hepatic benefits independent of weight loss in obese rats with HFpEF, but this is animal data and has not been replicated in humans (bioRxiv preprint, 2025)